Zomedica Corp.
ZOM · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.00 | -0.40 | 0.07 |
| FCF Yield | -9.37% | -11.70% | -5.61% | -4.38% |
| EV / EBITDA | -6.30 | -0.75 | -20.95 | -27.00 |
| Quality | ||||
| ROIC | -6.24% | -47.33% | -3.99% | -3.59% |
| Gross Margin | 67.00% | 67.80% | 95.31% | 72.32% |
| Cash Conversion Ratio | 0.76 | 0.74 | 0.10 | 0.63 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.06% | 8.12% | 10.03% | 12.96% |
| Free Cash Flow Growth | 18.14% | -0.70% | -12.22% | 25.13% |
| Safety | ||||
| Net Debt / EBITDA | 0.93 | 0.13 | 0.97 | 1.63 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.41 | 0.39 | 0.07 | 0.36 |
| Cash Conversion Cycle | 178.68 | 161.12 | 796.12 | 172.56 |